Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE).
Julie VeziantKarine PoirotCaroline ChevarinLucie CassagnesPierre SauvanetBenoit ChassaingFrederic RobinCatherine GodfraindNicolas BarnichDenis PezetBruno PereiraJohan GagniereMathilde BonnetPublished in: BMJ open (2020)
NCT03843905..
Keyphrases
- metabolic syndrome
- insulin resistance
- minimally invasive
- coronary artery bypass
- uric acid
- skeletal muscle
- late onset
- randomized controlled trial
- robot assisted
- cardiovascular risk factors
- rectal cancer
- radical prostatectomy
- weight loss
- surgical site infection
- type diabetes
- high fat diet induced
- amyotrophic lateral sclerosis
- weight gain
- adipose tissue
- community dwelling
- atrial fibrillation
- acute coronary syndrome
- early onset